L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.68 NOK -1.76% Market Closed
Market Cap: 331.4m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lytix Biopharma AS
Cash Equivalents Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Cash Equivalents
kr27.4m
CAGR 3-Years
-1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Cash Equivalents
kr25.3m
CAGR 3-Years
-39%
CAGR 5-Years
5%
CAGR 10-Years
20%
B
Bergenbio ASA
OSE:BGBIO
Cash Equivalents
kr200.1m
CAGR 3-Years
-30%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash Equivalents
kr170.3m
CAGR 3-Years
-1%
CAGR 5-Years
51%
CAGR 10-Years
7%
N
Nykode Therapeutics ASA
OSE:NYKD
Cash Equivalents
$136.5m
CAGR 3-Years
-8%
CAGR 5-Years
29%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash Equivalents
kr29.6m
CAGR 3-Years
-60%
CAGR 5-Years
-42%
CAGR 10-Years
-5%

See Also

What is Lytix Biopharma AS's Cash Equivalents?
Cash Equivalents
27.4m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Cash Equivalents amounts to 27.4m NOK.

What is Lytix Biopharma AS's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-11%

Over the last year, the Cash Equivalents growth was -71%. The average annual Cash Equivalents growth rates for Lytix Biopharma AS have been -1% over the past three years , -11% over the past five years .

Back to Top